<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Sharp Therapeutics Corp. — News on 6ix</title>
<link>https://6ix.com/company/sharp-therapeutics-corp</link>
<description>Latest news and press releases for Sharp Therapeutics Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 17 Apr 2026 22:13:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/sharp-therapeutics-corp" rel="self" type="application/rss+xml" />
<item>
<title>Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-announces-fourth-quarter-2025-results-closing-of-convertible-note-offering-and-adoption-of-semi-annual-reporting</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-announces-fourth-quarter-2025-results-closing-of-convertible-note-offering-and-adoption-of-semi-annual-reporting</guid>
<pubDate>Fri, 17 Apr 2026 22:13:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 17, 2026) - Sharp Therapeu...</description>
</item>
<item>
<title>Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-updates-on-901-for-gaucher-and-gba1-parkinsons-and-platform-programs</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-updates-on-901-for-gaucher-and-gba1-parkinsons-and-platform-programs</guid>
<pubDate>Fri, 10 Apr 2026 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeu...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-fourth-tranche-of-unsecured-convertible-note-offering</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-fourth-tranche-of-unsecured-convertible-note-offering</guid>
<pubDate>Fri, 10 Apr 2026 21:00:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeu...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-third-tranche-of-unsecured-convertible-note-offering</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-third-tranche-of-unsecured-convertible-note-offering</guid>
<pubDate>Thu, 02 Apr 2026 21:43:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 2, 2026) - Sharp Therapeut...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-second-tranche-of-unsecured-convertible-note-offering</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-second-tranche-of-unsecured-convertible-note-offering</guid>
<pubDate>Fri, 13 Mar 2026 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Second Tranche, the...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-first-tranche-of-unsecured-convertible-note-offering</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-closing-of-first-tranche-of-unsecured-convertible-note-offering</guid>
<pubDate>Fri, 27 Feb 2026 22:21:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Sharp Thera...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-private-placement-171000626</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-announces-private-placement-171000626</guid>
<pubDate>Mon, 02 Feb 2026 17:10:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce the terms of a proposed non-brokered private placement for an aggregate principal amount of up to US$3.0 million of unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). The Company anticipates that the initial closing of the.</description>
</item>
<item>
<title>Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-appoints-co-founder-of-national-gaucher-foundation-and-clinical-researcher-robin-ely-md-to-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-appoints-co-founder-of-national-gaucher-foundation-and-clinical-researcher-robin-ely-md-to-advisory-board</guid>
<pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
<description>PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or th...</description>
</item>
<item>
<title>Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-provides-update-on-non-brokered-private-placement-and-grant-of-options</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-provides-update-on-non-brokered-private-placement-and-grant-of-options</guid>
<pubDate>Fri, 19 Dec 2025 22:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Sharp Thera...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-reports-third-quarter-2025-results-and-development-update</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-reports-third-quarter-2025-results-and-development-update</guid>
<pubDate>Wed, 26 Nov 2025 12:35:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Sharp Thera...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trade Resumption - SHRX</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/canadian-investment-regulatory-organization-trade-resumption-shrx</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/canadian-investment-regulatory-organization-trade-resumption-shrx</guid>
<pubDate>Tue, 14 Oct 2025 15:39:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trade Resumption - SHRX Canada NewsWire ...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trading Halt - SHRX</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/canadian-investment-regulatory-organization-trading-halt-shrx</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/canadian-investment-regulatory-organization-trading-halt-shrx</guid>
<pubDate>Tue, 14 Oct 2025 15:27:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trading Halt - SHRX Canada NewsWire VA...</description>
</item>
<item>
<title>Sharp Therapeutics Arranges Non-Brokered Private Placement</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-arranges-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-arranges-non-brokered-private-placement</guid>
<pubDate>Tue, 14 Oct 2025 15:22:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Sharp Therap...</description>
</item>
<item>
<title>Sharp Therapeutics to Present Pipeline and Program Updates at World Orphan Drug Congress 2025</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-to-present-pipeline-and-program-updates-at-world-orphan-drug-congress-2025</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-to-present-pipeline-and-program-updates-at-world-orphan-drug-congress-2025</guid>
<pubDate>Wed, 08 Oct 2025 20:00:00 GMT</pubDate>
<description>PITTSBURGH, Pa. and TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" ...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Reports Second Quarter 2025 Results and Expands Market Presence with Listing On OTCQB</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-reports-second-quarter-2025-results-and-expands-market-presence-with-listing-on-otcqb</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-reports-second-quarter-2025-results-and-expands-market-presence-with-listing-on-otcqb</guid>
<pubDate>Fri, 29 Aug 2025 21:25:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Sharp Therape...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-engages-rho-inc-to-help-advance-compounds-into-clinical-trials-for-gaucher-disease</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-engages-rho-inc-to-help-advance-compounds-into-clinical-trials-for-gaucher-disease</guid>
<pubDate>Tue, 29 Jul 2025 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Sharp Therapeut...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-announces-results-from-annual-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-announces-results-from-annual-meeting-of-shareholders</guid>
<pubDate>Mon, 21 Jul 2025 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Sharp Therapeut...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Reports First Quarter 2025 Results</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-reports-first-quarter-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-reports-first-quarter-2025-results</guid>
<pubDate>Thu, 22 May 2025 21:45:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - May 22, 2025) - Sharp Therapeuti...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Nominates Clinical Candidate for Gaucher's Disease</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-nominates-clinical-candidate-for-gauchers-disease</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/sharp-therapeutics-corp-nominates-clinical-candidate-for-gauchers-disease</guid>
<pubDate>Tue, 13 May 2025 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Sharp Therapeuti...</description>
</item>
<item>
<title>STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.</title>
<link>https://6ix.com/company/sharp-therapeutics-corp/news/stx-partners-llp-and-newlin-investment-co-exercise-warrants-of-sharp-therapeutics-corp</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-therapeutics-corp/news/stx-partners-llp-and-newlin-investment-co-exercise-warrants-of-sharp-therapeutics-corp</guid>
<pubDate>Mon, 21 Apr 2025 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 21, 2025) - Sharp Therapeu...</description>
</item>
</channel>
</rss>